Merck & Co., Inc. Company IP News and Updates

In August, our much-anticipated fourth annual ANDA Litigation Intelligence Report made its entrance into the world of pharmaceutical litigation. This...

Statutory Petition Requirement Correctable Back in April I discussed the Patent Trial & Appeal Board’s (PTAB) evolving position that an...

CASE OF THE WEEK Gilead Sciences, Inc. v. Merck & Co., Inc., Appeal Nos. 2016-2302, -2615 (Fed. Cir. 2018) In...

On April 25th, a Fed. Cir. panel of Judges Taranto, Clevenger and Chen affirmed the unenforceability of two Merck patents...